These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1471492)

  • 1. Visual dysfunction in type II diabetic patients revealed by a hyperacuity test.
    Watkins R; Buckingham T
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):659-64. PubMed ID: 1471492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial.
    Trento M; Durando O; Lavecchia S; Charrier L; Cavallo F; Costa MA; Hernández C; Simó R; Porta M;
    Endocrine; 2017 Jul; 57(1):83-88. PubMed ID: 27628581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast sensitivity in diabetics with and without background retinopathy.
    Sokol S; Moskowitz A; Skarf B; Evans R; Molitch M; Senior B
    Arch Ophthalmol; 1985 Jan; 103(1):51-4. PubMed ID: 3977675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory and evidence for a clinical hyperacuity test.
    Whitaker D; Buckingham T
    Ophthalmic Physiol Opt; 1987; 7(4):431-5. PubMed ID: 3454922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doyne Memorial Lecture, 1978. Visual loss in patients with normal visual acuity.
    Arden GB
    Trans Ophthalmol Soc U K (1962); 1978; 98(2):219-31. PubMed ID: 286452
    [No Abstract]   [Full Text] [Related]  

  • 6. Early detection of changes in visual function in diabetes mellitus.
    Ismail GM; Whitaker D
    Ophthalmic Physiol Opt; 1998 Jan; 18(1):3-12. PubMed ID: 9666905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
    Jackson GR; Scott IU; Quillen DA; Walter LE; Gardner TW
    Br J Ophthalmol; 2012 May; 96(5):699-703. PubMed ID: 22174096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative development of movement hyperacuity and visual acuity in children.
    Buckingham TJ; Kelly SL
    Vision Res; 1996 Dec; 36(23):3851-6. PubMed ID: 8994586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal temporal frequencies in oscillatory movement hyperacuity measurements of visual function in cataract patients.
    Hurst M; Watkins R; Buckingham T
    Ophthalmic Physiol Opt; 1995 Jan; 15(1):49-52. PubMed ID: 7724219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of visual function and prognosis for patients with proliferative diabetic retinopathy with the low vision evaluator.
    Kunikata H; Nakagawa Y; Tamai M
    Tohoku J Exp Med; 2004 Nov; 204(3):229-36. PubMed ID: 15502423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central visual field changes using flicker perimetry in type 2 diabetes mellitus.
    Stavrou EP; Wood JM
    Acta Ophthalmol Scand; 2005 Oct; 83(5):574-80. PubMed ID: 16187995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment.
    Della Sala S; Bertoni G; Somazzi L; Stubbe F; Wilkins AJ
    Br J Ophthalmol; 1985 Feb; 69(2):136-42. PubMed ID: 3967001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus.
    Lopes de Faria JM; Katsumi O; Cagliero E; Nathan D; Hirose T
    Graefes Arch Clin Exp Ophthalmol; 2001 Sep; 239(9):643-8. PubMed ID: 11688662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperacuity test to evaluate vision through dense cataracts; research preliminary to a clinical study. I. Studies conducted at the University of California at Berkeley before travel to India.
    Enoch JM; Giraldez-Fernandez MJ; Knowles R; Huang D; Hunter A; LaBree L; Azen SP
    Optom Vis Sci; 1995 Sep; 72(9):619-29. PubMed ID: 8532303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with contrast sensitivity loss in diabetic patients.
    Dosso AA; Bonvin ER; Morel Y; Golay A; Assal JP; Leuenberger PM
    Graefes Arch Clin Exp Ophthalmol; 1996 May; 234(5):300-5. PubMed ID: 8740250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal Pupillography Identifies Changes in Visual Sensitivity According to Severity of Diabetic Retinopathy in Type 2 Diabetes.
    Sabeti F; Nolan CJ; James AC; Jenkins A; Maddess T
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4504-13. PubMed ID: 26200488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu.
    Smith TS; Szetu J; Bourne RR
    Br J Ophthalmol; 2007 Apr; 91(4):415-9. PubMed ID: 17077115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving visual prognosis of the diabetic patients during the past 30 years based on the data of the Finnish Register of Visual Impairment.
    Laatikainen L; Ojamo M; Rudanko SL; Summanen P; Keinänen-Kiukaanniemi S; Tuomilehto J; Herrala S; Uusitalo H
    Acta Ophthalmol; 2016 May; 94(3):226-31. PubMed ID: 26928978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of early diabetic retinopathy on rod system sensitivity.
    Greenstein VC; Thomas SR; Blaustein H; Koenig K; Carr RE
    Optom Vis Sci; 1993 Jan; 70(1):18-23. PubMed ID: 8430004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.